Rimidi Partners with athenahealth’s ‘More Disruption Please’ Program to Transform the Delivery of Diabetes Care
Atlanta, GA – June 28, 2017 – Rimidi, a provider of digital solutions to improve the management of chronic diseases, today announced a partnership with athenahealth, Inc. through athenahealth’s ‘More Disruption Please’ (MDP) program and as part of the athenahealth® Marketplace, this newly integrated application is now available to athenahealth’s growing network of more than 87,000 healthcare providers to deliver more efficient healthcare, improve patient quality of life, and decrease the financial burden to patients and payors.
“Rimidi delivers a valuable service for healthcare systems and practices as they focus on cost-effective delivery of high quality healthcare,” said Dr. Lucienne Ide, President and CEO, Rimidi. “Our platform, Diabetes+Me, provides an end-to-end solution for patients and providers with remote monitoring, population analytics and predictive modeling capabilities all focused on achieving patient health goals and creating a more efficient cycle of care.”
athenahealth is a network-enabled, results-oriented services company that offers medical record, revenue cycle, patient engagement, care coordination, and population health services for hospital and ambulatory clients. The company’s vision is to build a national health information backbone to help make healthcare work as it should. As an MDP partner, Rimidi joins a network of like-minded healthcare professionals who are looking to disrupt established approaches in healthcare that simply aren’t working, aren’t good enough, or aren’t advancing the industry and help providers thrive in the face of industry change.
To learn more about Rimidi’s new integrated application, please visit Rimidi’s product listing page on the Marketplace, https://www.athenahealth.com/healthcare-technology-partners/care-plan-management/rimidi.
About Rimidi Diabetes, Inc.
Rimidi is an Atlanta-based, woman-led digital health company bringing to market data analytics and disease management solutions. Its flagship product, Diabetes+Me™, is a software solution focused on empowering quality diabetes care for healthcare organizations and providers. Rimidi’s investors include Cox Enterprises; the JumpFund; SOURCE, a partnership between the Hitachi Foundation, Investor’s Circle and Village Capital; and the Sorenson Foundation. In January 2016, Rimidi was recognized as a top three healthcare technology by ACT The App Association. For more information, visit Rimidi-Serious Hope for Healthcare.
Mark Jarboe Rimidi, Inc. email@example.com 404-668-3314